Want to see BACK full AI Analyst Report?
Imac Holdings (BACK) AI Stock Analysis
Imac Holdings
(Other OTC:BACK)
IMAC Holdings has a low overall stock score due to significant financial challenges, negative valuation metrics, and technical indicators suggesting weak momentum. The risk of Nasdaq delisting further exacerbates the company's precarious position. The lack of earnings call data limits further insights into potential strategic actions or improvements.
Imac Holdings (BACK) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $378
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 0.0
- Beta (1Y)
- 0.64
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 15
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Imac Holdings Business Overview & Revenue Model
Company Description
IMAC Holdings, Inc. operates a network of advanced medical and regenerative care facilities across the United States. Through its outpatient clinics, the company delivers a range of regenerative, orthopedic, and minimally invasive treatments. These s...
How the Company Makes Money
IMAC Holdings generates revenue primarily through the operation of its medical clinics, which provide a range of healthcare services such as physical therapy, chiropractic care, and regenerative medicine treatments. These services cater to patients s...
Imac Holdings Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BACK, the sentiment is Negative. The current price of 0.00 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.04, and below the 200-day MA of 0.07, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 26.78 is Positive, neither overbought nor oversold. The STOCH value of 12.73 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BACK.
Imac Holdings Risk Analysis
Imac Holdings disclosed 45 risk factors in its most recent earnings report. Imac Holdings reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksImac Holdings Peers Comparison
Overall Rating
JYNT60Neutral
AMS53Neutral
CCEL52Neutral
PIII48Neutral
MNDR43Neutral- BACK25Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JYNT | 60Neutral | $99.43M | 26.50 | 22.00% | ― | -17.84% | ― |
| AMS | 53Neutral | $8.45M | -5.03 | -7.45% | ― | 3.97% | 28.88% |
| CCEL | 52Neutral | $42.01M | -23.24 | 15.84% | ― | -1.96% | -314.41% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| PIII | 48Neutral | $29.68M | -0.12 | 160.54% | ― | 2.81% | 26.63% |
| MNDR | 43Neutral | $1.17M | -0.04 | -35.24% | ― | 4.47% | 92.03% |
| BACK | 25Underperform | $378 | 0.00 | 45.60% | ― | ― | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| BACK | Imac Holdings, Inc. | 0.02 | -0.04 | -66.67% | |
| AMS | American Shared Hospital Services | 1.27 | -0.83 | -39.52% | |
| JYNT | Joint Corp | 7.03 | -0.83 | -10.56% | |
| CCEL | Cryo-Cell International | 5.21 | 0.72 | 16.04% | |
| PIII | P3 Health Partners Inc. | 4.03 | -4.82 | -54.46% | |
| MNDR | Mobile-health Network Solutions Class A | 0.98 | -13.18 | -93.10% |
Imac Holdings Corporate Events
IMAC Holdings Secures Promissory Note for Financial Stability
NeutralOn December 11, 2025, IMAC Holdings, Inc. issued a secured promissory note to a lender for $247,800 with a purchase price of $177,000, maturing on February 13, 2026. This financial move allows the company to prepay the principal without penalty and i...
IMAC Holdings Issues Secured Promissory Note
NeutralOn November 25, 2025, IMAC Holdings, Inc. issued a secured promissory note to a lender for $245,000, with a purchase price of $175,000. The note, which matures on February 13, 2026, allows for prepayment without penalty and includes standard covenant...
IMAC Holdings Issues Secured Promissory Note
NeutralOn November 14, 2025, IMAC Holdings, Inc. issued a secured promissory note to a lender for $210,000, with a purchase price of $150,000, maturing on February 13, 2026. The note allows prepayment without penalty and includes standard legal protections...
IMAC Holdings Issues Promissory Note for Liquidity
NeutralOn October 28, 2025, IMAC Holdings, Inc. issued an unsecured promissory note to a lender for $285,600, with a purchase price of $204,000, maturing on December 24, 2025. This financial maneuver allows the company flexibility in prepayment and includes...
IMAC Holdings Issues Unsecured Promissory Note
NeutralOn October 14, 2025, IMAC Holdings, Inc. issued an unsecured promissory note to a lender for $201,600, with a purchase price of $144,000, maturing on December 24, 2025. The note allows for prepayment without penalty and includes standard clauses for...
IMAC Holdings Issues Unsecured Promissory Note
NegativeOn September 26, 2025, IMAC Holdings, Inc. issued an unsecured promissory note to a lender for $296,800, with a purchase price of $212,000. The note, which matures on December 24, 2025, allows for prepayment without penalty and includes standard cove...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jan 30, 2025